Plasma α-synuclein and cognitive impairment in the Parkinson's Associated Risk Syndrome: A pilot study

Plasma α-synuclein and cognitive impairment in the Parkinson's Associated Risk Syndrome: A pilot study

Plasma total and nervous system derived exosomal (NDE) α-synuclein have been determined as potential biomarkers of Parkinson's disease (PD). To explore the utility of plasma α-synuclein in the prodromal phase of PD, plasma total and NDE α-synuclein were evaluated in baseline and 2-year follow-u...

Full description

Bibliographic Details
Main Authors: Hua Wang, Anzari Atik, Tessandra Stewart, Carmen Ginghina, Patrick Aro, Kathleen F. Kerr, John Seibyl, Danna Jennings, Poul Henning Jensen, Kenneth Marek, Min Shi, Jing Zhang
Format: Article
Language:English
Published: Elsevier 2018-08-01
Series:Neurobiology of Disease
Subjects:
Plasma
α-Synuclein
Parkinson's
Prodromal
Risk
Online Access:http://www.sciencedirect.com/science/article/pii/S0969996118301232

Internet

http://www.sciencedirect.com/science/article/pii/S0969996118301232

Similar Items